DOI: 10.1093/jjco/hyx011 , , PMID: 28334771 Issn Print: 0368-2811 Publication Date: 2017/05/01 Print Facebook Twitter LinkedIn Email Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study Seiichiro Ozono; Taiji Tsukamoto; Seiji Naito; Yasuo Ohashi; Takeshi Ueda; Tsutomu Nishiyama; Hideki Maeda; Hidehito Kusuoka; Rio Akazawa; Mototsugu Ito; Hideyuki Akaza + Author Information Author Information: Department of Urology, Hamamatsu University School of Medicine, Shizuoka Checking for direct PDF access through Ovid View on Journal Site Abstract Abstract unavailable for this article.
Facebook
Twitter
LinkedIn
Email
